Invitae claims Natera infringed DNA patents
13-05-2021
Natera and Illumina settle litigation, agree mutual licence
14-05-2020
Stanford sues Natera over transplant testing patents
27-03-2019
CI Photos / Shutterstock.com
DNA testing developer Natera is suing ArcherDX, a molecular technology company, for allegedly infringing a patent related to multiplex polymerase chain reaction (PCR) technology.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Natera, ArcherDX, patent, infringement, DNA, multiplex polymerase chain reaction, multiplex PCR, U.S. District Court of Delaware
